AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

CrowdStrike stock retreats following coronavirus-fueled earnings beat

2020-09-02

  MARKETWATCH PHOTO ILLUSTRATION/ISTOCKPHOTO|, CROWDSTRIKE CrowdStrike Holdings Inc.  shares retreated from 2020’s meteoric rise in the extended session Wednesday after the cloud-based cybersecurity company topped Wall Street estimates, with more businesses seeking to protect their systems as employees work from home. On a conference call, CrowdStrike CRWD, -1.12% co-founder andRead More →

‘Black Swan’ author says if investors don’t use a ‘tail hedge,’ he recommends ‘not being in the market’—‘We’re facing a huge amount of uncertainty’

2020-06-27

“ ‘If you don’t have a tail hedge, I suggest not being in the market we’re facing a huge amount of uncertainty.’  ” That’s “Black Swan: The Impact of the Highly Improbable” author Nassim Nicholas Taleb offering his view on the risks swirling in the market and a growing lack of clarityRead More →

Fed’s Kaplan worries economy’s recovery may be slowed if coronavirus health practices remain ‘uneven’

2020-06-14

MARKETWATCH FRONT PAGE Dallas Fed President Robert Kaplan said Sunday health-care procedures to combat the coronavirus were just as important as government funding for the nascent economic recovery and, to date, these efforts to reduce coronavirus infections have been “uneven.” See full story. Asymptomatic transmission of coronavirus appears to beRead More →